Serina Therapeutics, Inc. Accelerated Share Repurchases, Final Price Paid Per Share
Serina Therapeutics, Inc. (SER) reported Accelerated Share Repurchases, Final Price Paid Per Share of $11.31 per share for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare · last filed 2024-08-09
- Serina Therapeutics, Inc. accelerated share repurchases, final price paid per share for the quarter ending 2024-06-30 was $11.31.
- Serina Therapeutics, Inc. accelerated share repurchases, final price paid per share for the quarter ending 2024-03-31 was $14.87.
- Serina Therapeutics, Inc. accelerated share repurchases, final price paid per share for the quarter ending 2023-09-30 was $0.76.
- Serina Therapeutics, Inc. accelerated share repurchases, final price paid per share for the quarter ending 2022-06-30 was $0.71, a 51.37% decline year-over-year.
| Period end | Accelerated Share Repurchases, Final Price Paid Per Share 3 month | Accelerated Share Repurchases, Final Price Paid Per Share 6 month | Accelerated Share Repurchases, Final Price Paid Per Share 9 month |
|---|---|---|---|
| 2024-06-30 | $11.31 10-Q · filed 2024-08-09 | $11.72 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $14.87 10-Q · filed 2024-05-14 | ||
| 2023-09-30 | $0.76 10-Q · filed 2023-11-14 | $0.76 10-Q · filed 2023-11-14 | |
| 2022-09-30 | $0.79 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $0.71 10-Q · filed 2023-08-14 | $0.79 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $0.80 10-Q · filed 2023-05-12 | ||
| 2021-09-30 | $1.46 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $1.46 10-Q · filed 2022-08-12 | $1.46 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |